Dexcom | DXCM - Operating Expenses

Stock Price
71.64
Daily Change
-0.89 -1.23%
Monthly
5.90%
Yearly
-18.09%
Q1 Forecast
70.79

Dexcom reported $966.8M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Align Technology USD 811.05M 38.37M Sep/2025
AtriCure USD 134.06M 8.27M Sep/2025
Avanos Medical USD 158.83M 69.83M Sep/2025
Baxter International USD 2.63B 95.8M Sep/2025
Becton, Dickinson and Co. USD 5.07B 535M Sep/2025
Boston Scientific USD 4.03B 94M Sep/2025
Cooper Companies USD 924.8M 40.2M Sep/2025
Dexcom USD 966.8M 22.3M Sep/2025
Edwards Lifesciences USD 1.13B 26.7M Sep/2025
Globus Medical USD 886.57M 730.06M Sep/2025
Hologic USD 349.4M 447.1M Dec/2025
Insulet USD 588.6M 60.6M Sep/2025
Integra LifeSciences USD 1.04B 620.66M Sep/2025
J&J USD 18.97B 2.38B Dec/2025
Masimo USD 147M 159.4M Sep/2025
Medtronic USD 7.26B 283M Sep/2025
Merit Medical Systems USD 341.54M 6.11M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Solventum Corp USD 4.99B 3.04B Sep/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 272.12M 421K Sep/2025
Teleflex USD 3.82B 3.22B Sep/2025
West Pharmaceutical Services USD 3.05B 2.44B Sep/2025
Zimmer Biomet Holdings USD 1.66B 17.8M Sep/2025